Literature DB >> 16226801

Viewing ovarian cancer as a "chronic disease": what exactly does this mean?

Maurie Markman.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16226801     DOI： 10.1016/j.ygyno.2005.08.043

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  14 in total

Review 1.  Maintenance chemotherapy: an evolving and increasingly acceptable strategy in cancer management.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

2.  The "new" era of oral antineoplastic drug therapy: revisiting "old" concerns.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

3.  Use of progression-free survival as a valid endpoint in phase II cancer clinical trials.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2007-05       Impact factor: 5.075

4.  Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trials.

Authors:  Michelle L Harrison; Martin E Gore; David Spriggs; Stan Kaye; Alexia Iasonos; Martee Hensley; Carol Aghajanian; Ennapadam Venkatraman; Paul Sabbatini
Journal:  Gynecol Oncol       Date:  2007-07-05       Impact factor: 5.482

5.  Ovarian cancer survival: steady improvement, despite rhetoric to the contrary.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

6.  Rational study endpoints in anti-neoplastic agent regulatory approval trials in the gynecologic malignancies.

Authors:  Maurie Markman
Journal:  Womens Health (Lond)       Date:  2016-07

7.  Commentary: Implications of cancer managed as a "chronic illness".

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

Review 8.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

9.  An Example of Ovarian Cancer as a 'Chronic Disease Process' - 11-Year Survival with Multiple Treatments for Recurrent and Progressive Disease.

Authors:  Maurie Markman; Vinay Malviya
Journal:  Case Rep Oncol       Date:  2008-10-17

Review 10.  Pharmaceutical management of ovarian cancer : current status.

Authors:  Maurie Markman
Journal:  Drugs       Date:  2008       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.